Insulin-like growth factors I and II in evaluation of growth retardation.
about
Height velocity and IGF-I assessment in the diagnosis of childhood onset GH insufficiency: do we still need a second GH stimulation test?Determining the normal range for IGF-I, IGFBP-3, and ALS: new reference data based on current internal standards.Serum IGF-I and IGFBP-3 concentrations do not accurately predict growth hormone deficiency in children with brain tumours.Assessment of serum IGF-I concentrations in the diagnosis of isolated childhood-onset GH deficiency: a proposal of the Italian Society for Pediatric Endocrinology and Diabetes (SIEDP/ISPED).Insulin-like growth factor-binding protein-3 (IGFBP-3) blocks the effects of asthma by negatively regulating NF-κB signaling through IGFBP-3R-mediated activation of caspases.Serum IGF-1 and IGFBP-3 levels in healthy children between 0 and 6 years of age.Failure of IGF-I and IGFBP-3 to diagnose growth hormone insufficiency.Evaluation of growth hormone secretion and treatment.Growth hormone secretion in Turner's syndrome and influence of oxandrolone and ethinyl oestradiolCancer chemopreventive potential of volatile oil from black cumin seeds, Nigella sativa L., in a rat multi-organ carcinogenesis bioassayChanges in bone mass early after kidney transplantation.Isolated central hypothyroidism in young siblings as a manifestation of PROP1 deficiency: clinical impact of whole exome sequencingRelation of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 levels to growth retardation in extrahepatic portal vein obstruction.Prevalence and pattern of growth abnormalities in children with extrahepatic portal vein obstruction: Response to shunt surgery.Recombinant human IGF-1 (insulin-like growth factor) therapy: where do we stand today?Insulin-like growth factor-II: its role in metabolic and endocrine disease.Human growth hormone prevents the protein catabolic side effects of prednisone in humans.Do IGF-I concentrations better reflect growth hormone (GH) action in children with short stature than the results of GH stimulating tests? Evidence from the simultaneous assessment of thyroid function.The relationship between height velocity and growth hormone secretion in short prepubertal children.N-acetylcysteine and S-methylcysteine inhibit MeIQx rat hepatocarcinogenesis in the post-initiation stage.Growth hormone secretion and effects of growth hormone therapy on growth velocity and weight gain in children with Prader-Willi syndrome.Effect of combined treatment with gonadotropin releasing hormone analogue and growth hormone in patients with central precocious puberty who had subnormal growth velocity and impaired height prognosis.Reference levels of insulin-like growth factor I in the serum of healthy adults: comparison of four immunoassays.The diagnosis of severe growth hormone deficiency in elderly patients with hypothalamic-pituitary disease.Determinants of serum insulin-like growth factor I in growth hormone deficient adults as compared to healthy subjects.The relationship between the growth hormone and insulin-like growth factor axis in long-term survivors of childhood brain tumours.Effect of growth hormone on the low level of growth hormone binding protein in idiopathic short stature.
P2860
Q30709837-FE6CDDD1-3DA8-4F2B-A401-696E934E0533Q30847393-82D6C8CD-C34A-486D-8D37-0D8A463C34A1Q33723672-770C5157-4EA0-41D8-91FB-715677B81899Q34573132-EF6B0F47-857F-4CD8-9AC1-F3F66B99A73BQ34979016-8F3FD7A5-3916-4E07-8E53-ADCB0896A6BFQ35058052-0752AB8C-4E66-40F2-B7EC-7200343ACC3EQ35263119-F6CD4C03-82F8-46D1-ACC3-1712AD5D9AC1Q35354287-E3B3A0F4-386D-43B9-9466-3FAA9D4B2311Q35624507-CC21739F-0308-442C-A047-32DD47F96A39Q36216121-0F17A62E-07BA-44C7-A41D-2B4D48D5CD51Q36746963-1B0BC131-5532-410F-B3BA-8C94F7C9E408Q37211277-9F30947B-4BFD-46ED-BF0A-775DFF83F4DDQ37266050-3BA6C44B-9B25-41FA-9B37-93BE387D6C3FQ37409103-07E058BF-239E-4966-9DF4-7DE42B678435Q37957047-77F1D550-68C7-40B9-9FF8-462C13E98000Q38193208-DCC1087C-2472-4F8E-A5DD-0223975FB20EQ40347651-DA90D874-3586-4998-9121-05B3D1B6092FQ41955854-4BE8740C-03FD-4CF1-BC6A-0D2C28AEB90EQ44671751-05C256F6-8DD9-44C0-8E5F-FFAE1E188D40Q46843550-DC8FB003-00BF-44DD-8129-F8F16E462CEDQ47331870-6537EAF2-5769-4BBF-8CDC-E21132A61AEBQ47358387-846965C2-1775-4596-8655-D4CA78F55C06Q47422120-BD7C10BC-1F37-46E8-9ECD-3290B5BCCA43Q47833573-A6FC444E-11F0-443C-8610-D5BDBA88E91CQ47926813-EB624869-68ED-4E0A-A0F6-B722FDBC49FBQ48241252-73346D50-CDBB-4145-9F84-57C346744DBAQ54263158-B69B511C-A3B0-4488-A8F2-394DCD61567B
P2860
Insulin-like growth factors I and II in evaluation of growth retardation.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年学术文章
@wuu
1986年学术文章
@zh
1986年学术文章
@zh-cn
1986年学术文章
@zh-hans
1986年学术文章
@zh-my
1986年学术文章
@zh-sg
1986年學術文章
@yue
1986年學術文章
@zh-hant
name
Insulin-like growth factors I and II in evaluation of growth retardation.
@en
Insulin-like growth factors I and II in evaluation of growth retardation.
@nl
type
label
Insulin-like growth factors I and II in evaluation of growth retardation.
@en
Insulin-like growth factors I and II in evaluation of growth retardation.
@nl
prefLabel
Insulin-like growth factors I and II in evaluation of growth retardation.
@en
Insulin-like growth factors I and II in evaluation of growth retardation.
@nl
P2093
P1476
Insulin-like growth factors I and II in evaluation of growth retardation.
@en
P2093
P304
P356
10.1016/S0022-3476(86)80112-3
P407
P577
1986-09-01T00:00:00Z